Similar results were found through a screening of 65,057 white woman with breast cancer where a high or moderately increased risk of disease was found in relation with pathogenic mutations in ATM, CHEK2, PALB2, and RAD51D [28]. This evidence concerns the gene PALB2 and breast cancer.